Grape King Bio Ltd (TPE:1707)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
114.00
0.00 (0.00%)
Apr 28, 2026, 1:30 PM CST
-16.48%
Market Cap 16.89B
Revenue (ttm) 10.25B
Net Income (ttm) 1.22B
Shares Out 148.14M
EPS (ttm) 8.17
PE Ratio 13.95
Forward PE 11.54
Dividend 6.00 (5.26%)
Ex-Dividend Date Jun 17, 2026
Volume 167,880
Average Volume 208,486
Open 115.00
Previous Close 114.00
Day's Range 113.00 - 115.00
52-Week Range 112.00 - 139.00
Beta 0.36
RSI 28.22
Earnings Date May 13, 2026

About Grape King Bio

Grape King Bio Ltd, together with its subsidiaries, produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food in Taiwan, China, and internationally. It operates through Multi-Level Marketing; Distributors; Original Design Manufacturer/Original Equipment Manufacturer; and Sales Channel segments. The company provides health products and supplements; and microbial fermentation for mushroom mycelium, probiotics, and enzymes. It also offers functional ingredients for intestinal care, immunity regulatio... [Read more]

Sector Healthcare
Founded 1969
Employees 501
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 1707
Full Company Profile

Financial Performance

In 2025, Grape King Bio's revenue was 10.25 billion, a decrease of -8.14% compared to the previous year's 11.16 billion. Earnings were 1.22 billion, a decrease of -15.88%.

Financial Statements

News

There is no news available yet.